Toluene at environmentally relevant low levels disrupts differentiation of astrocyte precursor cells

Archives of Environmental Health

Volumn 57, Issue 3, 2002, Pages 232-238

  Yamaguchi, Hideaki ^a   Kidachi, Yumi ^a   Ryoyama, Kazuo ^a  

^a AOMORI UNIVERSITY   (Japan)

Author keywords

Air pollution; Gfap; Low level exposure; Sfme; Toluene

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; TOLUENE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; STEM CELL; TOXICITY TESTING;

ANIMALIA;

EID: 0036589776     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039890209602942     Document Type: Article

References (45)

1. Sheehan DM. Activity of environmentally relevant low doses of endocrine disruptors and the bisphenol A controversy: initial results confirmed. Proc Soc Exp Biol Med 2000; 224:57-60.
2. Nagel SCR, vom Saal FS, Thayer KA, et al. Relative binding affini-ty-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octyl-phenol. Environ Health Perspect 1997; 105:70-76.
3. Safe S. Bisphenol A and related endocrine disruptors. Toxicol Sci 2000; 56:251-252.
4. Vom Saal FS, Cooke PS, Palanza P, et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior Toxicol Ind Health 1998; 14:239-260.
5. Cagen CZ, Waechter JMJR, Dimond SS, et al. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol Sci 1999; 50:36-44.
6. Ashby J, Tin well H, Haseman J. Lack of effects for low dose levels of bisphenol A (BPA) and diethyIstiIbestrol (DES) on the prostate gland of CF1 mice exposed in utero. Regul Toxicol Pharmacol 1999; 30:156-166.
7. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med 2000; 224:61-68.
8. Vom Saal FS, Timms BG, Montano MM, et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci (USA) 1997; 94:2056-2061.
9. Sheehan DM, Willingham E, Gaylor D, et al. No threshold dose for estradiol-induced sex reversal of turtle embryos: how little is too much? Environ Health Perspect 1999; 107:155-159.
10. Laessig SA, McCarthy MM, Silbergeld EK. Neurotoxic effects of endocrine disruptors. Curr Opin Neurol 1999; 12:745-751.
11. Vom Saal FS, Sheehan DM. Challenging risk assessment. Forum for Appl Res Public Policy 1998; 13:11-18.
12. Verschueren K, Handbook of Environmental Data on Organic Chemicals. 2nd ed. New York: Van Nostrand Reinhold, 1983; pp 1103-1108.
13. United States Environmental Protection Agency. Chemical Summary for Toluene. Prepared by the Office of Pollution Prevention and Toxics. EPA 749-F-94-021a, August 1994.
14. Flanagan RJ, Ruprah M, Meredith TJ, et al. An introduction to the clinical toxicology of volatile substances. Drug Saf 1990; 5:359-383.
15. Cintra A, Aguirre JA, Andbjer B, et al. Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat. Neurosci Lett 1999; 274:5-8.
16. Von Euler M, Pham TH, Hillefors M, et al. Inhalation of low concentrations of toluene induces persistent effect on a learning retention task, beam-walk performance, and cerebrocortical size in the rat. Exp Neurol 2000; 163:1-8.
17. Ham RG, McKeehan WL. Media and growth requirements. Methods Enzymol 1979; 58:44-93.
18. Mather JP, Sato GH. The use of hormone-supplemented serum-free media in primary cultures. Exp Cell Res 1979; 124:215-221.
19. Lazarides E. Intermediate filaments: A chemically heterogeneous, developmentally regulated class of proteins. Ann Rev Biochem 1982;51:219-250.
20. Carmichael J, DeGraff WG, Gazdar AF, et al. Evaluation of a tet-razolium-based semiautomated colorimetric assay: Assessment of radiosensitivity. Cancer Res 1987; 47:943-946.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
22. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci (USA) 1979; 76: 4350-4354.
23. Balcarek JM, Cowan NJ, Structure of the mouse glial fibrillary acidic protein gene: implications for the evolution of the intermediate filament multigene family. Nucleic Acids Res 1985; 13: 5527-5543.
24. Thomsom JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
25. Loo DT, Fuquay JL, Rawson CL, et al. Extended culture of mouse embryo cells without senescence: Inhibition by serum. Science 1987;236:200-202.
26. Lendahl U, Zimmerman LB, McKay RDG. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-595.
27. Sakai Y, Rawson C, Lindburg K, et al. Serum and transforming growth factor P regulate glial fibrillary acidic protein in serum-free-derived mouse embryo cells. Proc Natl Acad Sci (USA) 1990; 87:8378-8382.
28. Loo DT, Althoen MC, Cotman CW. Down regulation of nestin by TGF-Á3 or serum in SFME cells accompanies differentiation into astrocytes. Neuroreport 1994; 15:1585-1588.
29. Loo DT, Althoen MC, Cotman CW. Differentiation of serum-free mouse embryo cells into astrocytes is accompanied by induction of glutamine synthase activity. Neurosci Res 1995; 42:184-191
30. Nakashima K, Yanagisawa M, Arakawa H, et al. Synergistic signaling in fatal brain by STAT3-Smad1 complex bridged by p300. Science 1999; 284:479-482
31. Sun Y, Nadal-Vicens M, Misono S, et al. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 2001; 104:365-376.
32. McWilliams ML, Chen GD, Fechter LD, Low-level toluene disrupts auditory function in guinea pigs. Toxicol Appli Phamacol 2000; 167:18-29.
33. Euler G, Fuxe K, Hansson T, et al., Effects of subacute toluene exposure on protein phosphorylation levels in rat frontoparietal and striated membranes. Acta Physiol Scand 1987; 131:113-118.
34. Euler G, Fuxe K, Agnati LF, et al. Ganglioside GM treatment prevents the effects of subacute exposure to toluene on N-(3H) propylnorapomorphine binding characteristics in rat striatal membranes. Neurosci Lett 1987; 82:181-184.
35. Carlsson A, Ljungquist E. Exposure to toluene: Concentration in subcutaneous adipose tissue. Scand J Work Environ Health 1982; 8:56-62.
36. American Conference of Governmental and Industrial Hygienists (ACGIH). Biological exposure indicies. Cincinnati, OH: ACGIH, BEI, 1984; pp 19-21.
37. Randolph TG. Fatigue and weakness of allergic origin (allergic toxemia) to be differentiated from "nervous fatigue" or neurasthenia. Ann Allergy 1945; 3:418-30.
38. Rea WJ, Mitchell MJ. Chemical sensitivity and the environment. Immunology Allergy Practice 1982; 9/10:21-31.
39. Rea WJ, Pan Y, Laseter JL, Johnson AR, Fenyves EJ. Toxic volatile organic hydrocarbons in chemically sensitive patients. Clinical Ecology 1987; 5:70-74.
40. Gospe SM, Zhou SS. Prenatal exposure to toluene results in abnormal neurogenesis and migration in rat somatosensory cortex. Pediatr Res 2000; 47:362-368.
41. Gospe SM, Zhou SS. Toluene abuse embryopathy: longitudinal neurodevelopmental effects of prenatal exposure to toluene in rats. Reprod Toxicol 1998; 12:119-126.
42. World Health Organization (WHO). Air Quality Guidelines for Europe. WHO regional publications, European series no. 23. Copenhagen, Denmark: World Health Organization, Regional Office for Europe; 1987.
43. Environment Canada. Priority Substances List Assessment Report—Toluene. Canadian Environmental Protection Act. Ottawa, Canada: Environment Canada, Health and Welfare Canada, Minister of Supply and Services Canada; 1992.
44. Voog L, Eriksson T. Toluene-induced decrease in rat plasma concentrations of tyrosine and tryptophan. Acta Pharmacol Toxicol 1984; 54:151-153.
45. Heron DS, Shinitzky M, Hershkowitz M, et al. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci 1980; 77:7463-7467.